Lexeo Therapeutics, Inc. (LXEO) Operating cash flow 2022–2025
Lexeo Therapeutics, Inc. (LXEO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$98.6MFY2025 · since FY2022: -$54.6M → -$98.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$98.6M | -21.5% |
| FY2024 | -$81.2M | -36.4% |
| FY2023 | -$59.5M | -9.0% |
| FY2022 | -$54.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice